Fundraising FoxLinguaFlex
Weston, US · Delaware corporation
Find your way into LinguaFlex
Sign up to see every warm intro you have to LinguaFlex
- Paths you didn't know you had: your email and LinkedIn already hold routes to the LinguaFlex team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
LinguaFlex develops a minimally-invasive, investigational device placed in the underside of the tongue to treat obstructive sleep apnea and snoring by keeping the airway open during sleep. The device is placed in a 10-minute outpatient procedure under light sedation and is being evaluated for patients with sleep apnea; it has not yet received FDA clearance in the US.
Founders & leadership
Board
MO
Michele OllierBoard director
RL
Remy LuthringerBoard director
MF
Mark FunstonBoard director
TL
Timothy LanglossBoard director
Reported raises · per SEC filings
Form D private placements$3.6M disclosed across 1 round · 2015
▶$3.6MraisedFeb 2016 · 9 investors · Other Health CareRule 506(b)
▶$3.6MraisedFeb 2016 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Remy LuthringerDirector
- Mark FunstonDirector
- Michele OllierDirector
- Ira SandersDirector
- John MiclotExecutive Officer, Director
- Timothy LanglossDirector
- Offering amount
- $7M
- Amount sold
- $3.6M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does LinguaFlex do?
- LinguaFlex develops a minimally-invasive, investigational device placed in the underside of the tongue to treat obstructive sleep apnea and snoring by keeping the airway open during sleep. The device is placed in a 10-minute outpatient procedure under light sedation and is being evaluated for patients with sleep apnea; it has not yet received FDA clearance in the US.
- Who founded LinguaFlex?
- LinguaFlex was founded by Dr. Ira Sanders.
- How much funding has LinguaFlex raised?
- LinguaFlex has disclosed $3.6M raised across 1 round.
- Where is LinguaFlex headquartered?
- LinguaFlex is headquartered in Weston, US.